Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Review of PI3K/mTOR inhibitors entering clinical trials to treat triple negative breast cancersRecent Patents on Anti-Cancer Drug Discovery, 2016, 11 (3), pp.283-296. ⟨10.2174/1574892811666160519113731⟩
Journal articles
hal-01367247v1
|